Earnings Call · Q4 FY2024·2025-03-27

Q4 24EPS -18.35%·Rev n/aQ3 24EPS +11.11%·Rev n/aQ2 24EPS +13.16%·Rev n/aQ1 24EPS -100.00%*·Rev n/a⚠ consensus missing

Spero Therapeutics, Inc. SPRO

Shai Biran — CEO

Esther Rajavelu — See Remarks

Tim Keutzer — Chief Operating Officer

−2.0%1d on move date−0.5% vs SPY3d−2.6%5d−16.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SPRO calls or request research access.

More SPRO calls Browse calls Request research access